Enzon and Viskase amend merger agreement terms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Caribou Biosciences to halt CAR-T programs, explore sale
- Sportradar to sell Synergy Sports coaching unit for $170M
- Emera and Canadian Utilities agree to merge in $72B all-share deal
Enzon and Viskase Announce Amendment to Merger Agreement
October 24, 2025 4:50 PM EDTCRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (Enzon or the Company) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (Viskase) today announced that they have entered into an amendment (the Amendment) to the previously disclosed Agreement and Plan of Merger (the Merger Agreement), pursuant to which Viskase will merge with and into a wholly owned subsidiary of Enzon in an all-stock transaction (the Merger). The Amendment was entered into to reflect recent developments in the operations of Viskase during the past several... More



